Whole-Genome Sequencing Reveals Complex Genomic Features Underlying Anti-CD19 CAR T-Cell Treatment Failure in Lymphoma
Demographics (4)
- AGE - Subject age at enrollment (phv00508206.v1.p1)
- AGE_ONSET - Disease onset age (phv00508207.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00508213.v1.p1)
- SEX - Biological sex (phv00508201.v1.p1)
Disease Events (2)
- AFFECTION_STATUS - Case control status of the subject for diffuse large B cell lymphoma (DLBCL); All subjects are DLBCL patients. (phv00508205.v1.p1)
- IS_DEAD - Death status (phv00508216.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte Type (phv00508210.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00508209.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00508200.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00508212.v1.p1)
- IS_TUMOR - Tumor status (phv00508211.v1.p1)
- OS - Overall survival (phv00508218.v1.p1)
- PFS - Progression-free survial (phv00508217.v1.p1)
- PROGRESSED_OR_DIED - Progression status (phv00508215.v1.p1)
- SAMPLE_CONDITION - Germline, PreCART, or PostCART (phv00508214.v1.p1)
- SAMPLE_ID - Sample ID (phv00508208.v1.p1)
- SAMPLE_ID - Sample ID (phv00508203.v1.p1)
- SUBJECT_ID - Subject ID (phv00508204.v1.p1)
- SUBJECT_ID - Subject ID (phv00508199.v1.p1)
- SUBJECT_ID - Subject ID (phv00508202.v1.p1)